Language

Target groups›Logistics & warehousing›Supply-chain resilience & emergency logistics

Service area · GDP logistics

Prioritise, protect and test critical pharmaceutical supply chains

tiger.PHARMA develops business-continuity, alternative-warehouse, second-source and recovery models.

Discuss a pharmaceutical logistics project →
Supply-chain resilience and emergency logistics

Resilient pharma supply chain · BCP · alternative warehouse · recovery

Supply-chain resilience and emergency logistics

tiger.PHARMA develops business-continuity, alternative-warehouse, second-source and recovery models.

Resilience requires a defensible business-impact analysis, qualified alternatives, clear decision rights and regularly tested recovery objectives.

tiger.PHARMA Expertise

Topics we master

Analyse supply criticality and dependencies

Analyse supply criticality and dependencies

Resilience requires a defensible business-impact analysis, qualified alternatives, clear decision rights and regularly tested recovery objectives.

  • Business impact, product criticality and maximum tolerable outage
  • Single points of failure, scenarios, indicators and triggers
Design qualified alternatives and decision rules

Design qualified alternatives and decision rules

tiger.PHARMA translates product, quality, data and business requirements into an implementable target state and supports selection, qualification, migration, go-live and ongoing control.

  • Pre-qualified second source, alternative warehouse and lanes
  • Emergency stock, prioritisation, crisis roles and communication
Test crisis response, recovery and BCP effectiveness

Test crisis response, recovery and BCP effectiveness

Metrics, deviations, changes and periodic reviews keep the process demonstrably effective.

  • RTO/RPO, data restore, manual fallback and recovery
  • Tabletop and operational exercises, lessons, CAPA and re-test
From requirements to stable operation

From requirements to stable operation

tiger.PHARMA translates product, quality, data and business requirements into an implementable target state and supports selection, qualification, migration, go-live and ongoing control.

  • URS, RFI/RFP and decision model
  • SOPs, quality agreement and responsibilities
  • Pilot, acceptance, hypercare and KPI review

FAQ

Frequently asked questions

How should a pharmaceutical logistics BCP be tested?

Resilience requires a defensible business-impact analysis, qualified alternatives, clear decision rights and regularly tested recovery objectives.

How does tiger.PHARMA support implementation?

tiger.PHARMA structures requirements, selection, qualification, agreements, SOPs, tests, go-live and ongoing control. Scope depends on the product, authorisations, site and operating model.

© 2026 tiger.PHARMA